Kinome-wide polypharmacology profiling of small molecules by multi-task graph isomorphism network approach
Acta Pharmaceutica Sinica B, ISSN: 2211-3835, Vol: 13, Issue: 1, Page: 54-67
2023
- 20Citations
- 26Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations20
- Citation Indexes20
- 20
- CrossRef1
- Captures26
- Readers26
- 26
- Mentions2
- News Mentions2
- News2
Most Recent News
Acta Pharmaceutica Sinica B Volume 13, Issue 1 publishes
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/13/issue/1 Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB
Article Description
Prediction of the interactions between small molecules and their targets play important roles in various applications of drug development, such as lead discovery, drug repurposing and elucidation of potential drug side effects. Therefore, a variety of machine learning-based models have been developed to predict these interactions. In this study, a model called auxiliary multi-task graph isomorphism network with uncertainty weighting (AMGU) was developed to predict the inhibitory activities of small molecules against 204 different kinases based on the multi-task Graph Isomorphism Network (MT-GIN) with the auxiliary learning and uncertainty weighting strategy. The calculation results illustrate that the AMGU model outperformed the descriptor-based models and state-of-the-art graph neural networks (GNN) models on the internal test set. Furthermore, it also exhibited much better performance on two external test sets, suggesting that the AMGU model has enhanced generalizability due to its great transfer learning capacity. Then, a naïve model-agnostic interpretable method for GNN called edges masking was devised to explain the underlying predictive mechanisms, and the consistency of the interpretability results for 5 typical epidermal growth factor receptor (EGFR) inhibitors with their structure‒activity relationships could be observed. Finally, a free online web server called KIP was developed to predict the kinome-wide polypharmacology effects of small molecules ( http://cadd.zju.edu.cn/kip ).
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211383522002118; http://dx.doi.org/10.1016/j.apsb.2022.05.004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85133863677&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36815050; https://linkinghub.elsevier.com/retrieve/pii/S2211383522002118; https://dx.doi.org/10.1016/j.apsb.2022.05.004; http://sciencechina.cn/gw.jsp?action=cited_outline.jsp&type=1&id=7423022&internal_id=7423022&from=elsevier
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know